Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,014 across all filing types
Latest filing 2015-11-06 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
独立董事提名人声明
Board/Management Information Classification · 95% confidence The document is a public statement from the board of directors nominating candidates for independent directors of the company. It details the qualifications, compliance with legal and regulatory requirements, and independence of the nominees. There is no financial data, no report of financial results, no voting results, no meeting materials, and no mention of any report publication. The content is focused on board/management information specifically about director nominations. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is under 5,000 characters and is a detailed statement, not a brief announcement or certification, so it is not RNS or RPA.
2015-11-06 Chinese
第二届董事会第二十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from the board of directors of 福安药业（集团）股份有限公司 regarding the resolutions passed at the 27th meeting of the second board of directors. It includes the nomination of candidates for the third board of directors and details about the upcoming third extraordinary general meeting of shareholders in 2015. The document contains biographies of the nominated directors and voting results. There is no financial data, earnings information, or audit content. The focus is on board member nominations and meeting resolutions, which fits the category of Board/Management Information (MANG). The document length is 3764 characters, which is relatively short but contains substantive content about board changes rather than just an announcement of a report or meeting notice. Therefore, the classification is MANG with high confidence.
2015-11-06 Chinese
关于召开2015年第三次临时股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about convening the 2015 third extraordinary general meeting of shareholders for 福安药业 (Fuan Pharmaceutical Group Co., Ltd.). It includes information about the meeting date, voting procedures (both onsite and online), agenda items focusing on the election of board directors and supervisors, registration details, and proxy authorization forms. The content is focused on informing shareholders about the meeting logistics and agenda, specifically the election of board members and supervisors, which is a typical subject of shareholder meetings. There is no financial data, earnings information, or audit content. The document is not a report itself but a formal notification for a shareholders' meeting. Therefore, it fits the category of AGM Information (AGM-R).
2015-11-06 Chinese
重大资产重组进展暨延期复牌公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the progress and delay of a major asset restructuring and the extension of trading suspension (stock halt) due to this restructuring. It mentions the company's application to the stock exchange for an extension of the suspension and plans to disclose the restructuring plan or report by a future date. The content focuses on the status and procedural updates of a major asset reorganization, not the actual restructuring report or financial statements. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as major asset restructurings and related trading suspensions.
2015-11-03 Chinese
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from 福安药业 (Fuan Pharmaceutical Group) regarding the progress of a major asset restructuring (重大资产重组进展公告). It mentions ongoing work related to the restructuring, including audits, evaluations, and due diligence, and states that the stock remains suspended pending further disclosure. The document is relatively short (752 characters) and serves as a progress update on a capital restructuring event rather than a full financial report or detailed filing. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as major asset restructurings.
2015-10-28 Chinese
2015年第三季度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (364 characters) stating that the company's 2015 third quarter report has been published and is available on a regulatory website. It does not contain the actual financial data or substantive analysis from the report itself, but merely informs investors to refer to the full report elsewhere. According to the MENU VS MEAL RULE, this is a Report Publication Announcement (RPA), not the actual Interim/Quarterly Report (IR).
2015-10-23 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.